一个多变量预测模型,用于治疗阿姆洛迪平在儿科初级高血压的疗效
1Department of Cardiology, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
一个新的诺莫格拉姆模型预测使用诸如高胰岛素血症和胰岛素抵抗等生物标志物在儿科高血压中成功治疗阿姆洛迪平. 这种工具有助于为患有初级高血压的儿童选择有效的阿姆洛迪平剂量.
科学领域:
- 心血管医学 心血管医学
- 儿科内分泌学 儿科内分泌学
- 药物基因组学 药物基因组学
背景情况:
- 儿科初级高血压缺乏基于生物标志物的预测模型来确定阿姆洛迪平的疗效.
- 氨基是儿童高血压的常见治疗方法,但预测反应是具有挑战性的.
研究的目的:
- 确定用于预测小儿初级高血压 (PH) 治疗amlodipine疗效的生物标志物.
- 建立一个基于生物标志物的诺莫格拉姆模型,用于预测儿科PH的阿姆洛迪平治疗反应.
主要方法:
- 一项前性观察性研究包括165名患有PH的儿童和青少年,他们接受了阿姆洛迪平治疗.
- 分析了基线数据以确定反应的预测因素;使用多变量回归开发了一个名录模型.
- 使用统计方法评估模型性能,包括通过引导抽样进行内部验证.
主要成果:
- 超胰岛素血症,胰岛素耐药性,基线内末林-1水平和安洛迪平剂量独立地与治疗疗效相关.
- 诺莫格拉姆模型显示出高预测值 (AUC = 0.967),91.0%的灵敏度和92.1%的特异性.
- 内部验证显示了良好的校准 (c-统计 = 0.865).
结论:
- 一个包含关键生物标志物和剂量的诺莫格拉姆模型有效地预测了阿姆洛迪平在儿科PH的疗效.
- 这个模型有可能指导阿姆洛迪平的选择,以改善儿科高血压的治疗结果.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
